BIONATUS-BIOGESTIL
Natural health product licensed in Canada
- Other names
- FITOTHERS-BOLDO
- Licence holder
- Laboratoire Bionatus Pharmacognosique Inc.
- NPN or DIN-HM
- 80095337
- Status
- Active licence
- Licence date
- 15 November 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Peumus boldus Source : Feuille Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 500 mg Potency : 2.5 mg Boldine | 250 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve digestive disturbances (dyspepsia) and stimulate digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Patients with history of hypersensitivity and allergy to any component of this product should not make use of Biogestil/Boldo. Patients with biliary tract obstruction, gallstones, inflammation or bile duct cancer and pancreas cancer should not use Biogestil/Boldo. This product should not be used by patients with severe liver disease such as viral hepatitis,cirrhosis or toxic hepatitis. Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have kidney or liver disorders.
- Effets indésirables connus
At the recommended doses, no adverse effects are known. Inform your pharmacist or doctor about the occurrence of any adverse reactions following the use of this product. Also inform the company (Bionatus) through its customer service.
- Contre-indications
Biogestil/Boldo is also contraindicated in pediatric populations as well as in individuals with hypersensitivity or allergy to any of the components of the formulation. Do not use this product if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80095337
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.